South Africa Cannabis Industry Presses for Regulatory Action

South Africa’s licensed cannabis operators are losing business to an unregulated grey market while the government works through what has become nearly a decade of policy consultation without commercial implementation. That trajectory may be approaching a reckoning — not because the government has moved, but because the industry has started pressing the issue directly.

On June 2, 2026, Charl Botha, a legal strategist who presented before Parliament’s trade committee in March 2026, wrote directly to four government Directors-General and two parliamentary committees. The letter draws on more than 60 submissions, policy proposals, and technical recommendations that Botha says his clients have submitted over two years — none of which have received formal government response. The core argument: South Africa is producing consultation without implementation, and licensed businesses are paying for the gap.

Eight years after the court, still no commercial framework

The legal foundation for cannabis reform in South Africa dates to the Constitutional Court’s unanimous ruling in September 2018 in Minister of Justice and Constitutional Development v Prince, which found that criminalizing private cannabis use and cultivation by adults violated constitutional privacy rights. Parliament had 24 months to amend the affected legislation. Six years later, the Cannabis for Private Purposes Act was signed in May 2024 — but the Act has not yet formally commenced. Implementing regulations that would set legal possession and cultivation quantities must still receive Parliamentary approval before taking effect, leaving the 2018 court ruling as the operative legal basis for private use in the interim. Commercial regulation was explicitly deferred to a separate legislative process.

That separate process is moving slowly. The National Cannabis Master Plan, now administered by the Department of Trade, Industry and Competition under an Inter-Ministerial Committee, spans ten government departments across nine policy pillars and has been in development for the better part of seven years. The Hemp and Cannabis Commercialisation Policy — the document intended to formally open commercial trade — was expected to reach Cabinet by April 2026. It has not. The overarching Cannabis Bill, which would unify private use, commercial cultivation, and manufacturing under a single statute, is not scheduled to reach Parliament until mid-2027.

For businesses considering South Africa as a market or export destination, the structure of that delay matters. The South African Health Products Regulatory Authority has issued more than 116 active medical cannabis cultivation licenses and 120 export licenses. The hemp and cannabis sector employs more than 90,000 people nationwide, according to the Department of Trade, Industry and Competition. But domestic commercial sale remains prohibited, and those holding cultivation or export licenses operate in a regulatory environment where the commercial layer is still being designed.

As Parliament’s Portfolio Committee on Trade, Industry and Competition noted after its March 2026 oversight briefing, estimates put the illicit domestic cannabis market at approximately R36 billion. The legal market remains significantly smaller. That ratio — a massive informal economy alongside a tightly constrained legal one — captures why operators have grown impatient with further delay.

Banking, pilots, and the cost of the gap

The problem for licensed operators extends beyond market access. Botha’s letter highlights that businesses holding licenses from South Africa’s health products regulator are being refused standard banking and payment processing services. Financial institutions are classifying cannabis activity as prohibited regardless of its legal status — a familiar problem in jurisdictions where statutory reform has outrun banking sector guidance.

“A modern cannabis framework must be assessed not only through legislation and policy,” Botha wrote, “but also through the ability of lawful participants to access essential commercial infrastructure, including banking, payment systems, insurance and investment capital.”

Among the unaddressed submissions Botha cites is a 100-site compliance pilot framework designed to generate real-world traceability and public health data at no cost to the government. Two white papers — one on packaging, labeling, and traceability; another on indigenous knowledge systems and traditional community participation — were circulated to relevant departments and received no formal response. These are not abstract proposals: they represent the regulatory infrastructure that allows a licensed market to operate alongside enforcement rather than in spite of it.

Constitutional litigation is now underway across multiple stakeholder groups — another indicator that the industry is running out of patience with administrative reform that has not kept pace with stated government ambition.

South Africa is not unique in this pattern. Across the African continent, the gap between constitutional or legislative recognition and workable commercial frameworks has been a recurring problem, a dynamic MyCannabis has tracked across the region. President Cyril Ramaphosa declared in his 2025 State of the Nation Address that the country aims to lead in commercial cannabis and hemp production. As Botha’s letter states plainly: “South Africa’s cannabis future cannot remain indefinitely suspended between constitutional recognition and regulatory implementation.”

The Cannabis Bill is due before Parliament by mid-2027. The Commercialisation Policy has not yet cleared Cabinet. For the licensed operators waiting on both, that timetable is not a vision — it is the floor the sector needs to begin functioning commercially.